ID: ALA3976653

Max Phase: Preclinical

Molecular Formula: C27H29F4N7O2

Molecular Weight: 559.57

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cn1cnc2c(-c3ccc(OCCC4CCN(CC(=O)N5CC[C@H](F)C5)CC4)c(C(F)(F)F)c3)nc(C#N)nc21

Standard InChI:  InChI=1S/C27H29F4N7O2/c1-36-16-33-25-24(34-22(13-32)35-26(25)36)18-2-3-21(20(12-18)27(29,30)31)40-11-7-17-4-8-37(9-5-17)15-23(39)38-10-6-19(28)14-38/h2-3,12,16-17,19H,4-11,14-15H2,1H3/t19-/m0/s1

Standard InChI Key:  UTMBCSJDDRBORC-IBGZPJMESA-N

Associated Targets(Human)

CTSS Tchem Cathepsin S (3285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ctss Cathepsin S (94 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 559.57Molecular Weight (Monoisotopic): 559.2319AlogP: 3.97#Rotatable Bonds: 7
Polar Surface Area: 100.17Molecular Species: NEUTRALHBA: 8HBD: 0
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.68CX LogP: 3.37CX LogD: 2.90
Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.40Np Likeness Score: -1.31

References

1.  (2016)  Nitrogen-containing bicyclic aromatic heterocyclic compound, 

Source

Source(1):